Ballew Advisors, Inc - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ballew Advisors, Inc ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$0280.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders